Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders

Journal of Bone and Mineral Research

Volumn 30, Issue 9, 2015, Pages 1667-1675

  LeBlanc, Claire M A ^a   Ma, Jinhui ^b   Taljaard, Monica ^b   Roth, Johannes ^b   Scuccimarri, Rosie ^a   Miettunen, Paivi ^c   Lang, Bianca ^d   Huber, Adam M ^d   Houghton, Kristin ^e   Jaremko, Jacob L ^f   Ho, Josephine ^c   Shenouda, Nazih ^b   Matzinger, Mary Ann ^b   Lentle, Brian ^e   Stein, Robert ^g   Sbrocchi, Anne Marie ^a   Oen, Kiem ^h   Rodd, Celia ^h   Jurencak, Roman ^b   Cummings, Elizabeth A ^d   Couch, Robert ⁱ   Cabral, David A ^e   Atkinson, Stephanie ^j   Alos, Nathalie ^k   Rauch, Frank ^a   Siminoski, Kerry ^f   Ward, Leanne M ^b   more..

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

adolescents; bone density; children; glucocorticoids; rheumatic disorders; vertebral fractures

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; VITAMIN D; JUVENILE-ONSET SCLERODERMA;

ARTICLE; BASAL METABOLIC RATE; BODY MASS; BONE AGE; BONE DENSITY; CALCIUM INTAKE; CHILD; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; EOSINOPHILIC FASCIITIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JUVENILE DERMATOMYOSITIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; RHEUMATIC DISEASE; RISK FACTOR; SCLERODERMA; SPINE FRACTURE; SPINE RADIOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; ADOLESCENT; ARTHRITIS, JUVENILE; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPLICATION; DERMATOMYOSITIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOPOROSIS; PROPORTIONAL HAZARDS MODEL; RHEUMATIC DISEASES; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SPINAL FRACTURES;

ADOLESCENT; ARTHRITIS, JUVENILE; BONE DENSITY; CHILD; COHORT STUDIES; DERMATOMYOSITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OSTEOPOROSIS; PROPORTIONAL HAZARDS MODELS; RHEUMATIC DISEASES; RISK FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SPINAL FRACTURES; SYSTEMIC VASCULITIS;

EID: 84939572165     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2511     Document Type: Article

References (40)

1. Varonos S, Ansell BM, Reeve J,. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int. 1987; 41 (2): 75-8.
2. Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB,. Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis. 2006; 65 (8): 1074-9.
3. Burnham JM, Shults J, Sembhi H, Zemel BS, Leonard MB,. The dysfunctional muscle-bone unit in juvenile idiopathic arthritis. J Musculoskelet Neuronal Interact. 2006; 6 (4): 351-2.
4. Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB,. Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits. Arthritis Rheum. 2008; 58 (8): 2518-27.
5. Burnham JM., Inflammatory diseases and bone health in children. Curr Opin Rheumatol. 2012; 24 (5): 548-53.
6. Carberry GA, Pooler BD, Binkley N, Lauder TB, Bruce RJ, Pickhardt PJ., Unreported vertebral body compression fractures at abdominal multidetector CT. Radiology. 2013; 268 (1): 120-6.
7. Makitie O, Doria AS, Henriques F, et al., Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005; 146 (3): 395-401.
8. Nakhla M, Scuccimarri R, Duffy KN, et al., Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia. J Pediatr. 2009; 154: 438-43.
9. Regio P, Bonfa E, Takayama L, Pereira R,. The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus. 2008; 17 (9): 787-92.
10. Reyes ML, Hernandez MI, King A, et al., Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures. Clin Exp Rheumatol. 2007; 25 (2): 329-35.
11. Valta H, Lahdenne P, Jalanko H, Aalto K, Makitie O., Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007; 34 (4): 831-6.
12. Huber AM, Gaboury I, Cabral DA, et al., Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken). 2010; 62 (4): 516-26.
13. Rodd C, Lang B, Ramsay T, et al., Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken). 2012; 64 (1): 122-31.
14. Ogden CL, Kuczmarski RJ, Flegal KM, et al., Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109 (1): 45-60.
15. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva, Switzerland: World Health Organization 2006. p 229-300.
16. Pritchard JM, Seechurn T, Atkinson SA,. A food frequency questionnaire for the assessment of calcium, vitamin D and vitamin K: a pilot validation study. Nutrients. 2010; 2 (8): 805-19.
17. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al., Editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. C Available from: http://www.ncbi.nlm.nih.gov/books/NBK56070/
18. Hay J., Development and validation of the Habitual Activity Estimation Scale. In:, Armstrong N, editor. Children and exercise, XIX. 2nd ed. Vol. 2006. Exeter: Singer Press 1997. p 125-9.
19. Marks SD, Pilkington C, Woo P, Dillon MJ,. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). 2004; 43 (9): 1186-9.
20. Falcone A, Cassone R, Rossi E, Pistorio A, Martini A, Ravelli A,. Inter-observer agreement of the physician's global assessment of disease activity in children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2005; 23 (1): 113-6.
21. Rider LG, Feldman BM, Perez MD, et al., Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1997; 40 (11): 1976-83.
22. Genant HK, Wu CY, van Kuijk C, Nevitt MC,. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993; 8 (9): 1137-48.
23. Greenland S, Rothman KJ,. Measures of occurrence. In: Rothman KJ, Greenl and S, Lash TL, editors. Modern epidemiology. Philadelphia: Lippincott Williams and Wilkins 2008. p 33-50.
24. Glynn RJ, Buring JE,. Ways of measuring rates of recurrent events. BMJ. 1996; 312 (7027): 364-7.
25. Therneau TM, Grambsch PM., Modeling survival data: extending the Cox model. New York: Springer-Verlag 2000.
26. Abrahamowicz M, MacKenzie T, Esdaile JM., Time-dependent hazard ratio: modeling and hypothesis testing with application in lupus nephritis. J Am Stat Assoc. 1996; 91: 1432-9.
27. Canalis E, Mazziotti G, Giustina A, Bilezikian JP,. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007; 18 (10): 1319-28.
28. Feber J, Gaboury I, Ni A, et al., Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int. 2012; 23 (2): 751-60.
29. Alos N, Grant RM, Ramsay T, et al., High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clinl Oncol. 2012; 30 (22): 2760-7.
30. Phan V, Blydt-Hansen T, Feber J, et al., Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int. 2014; 25 (2): 627-37.
31. Lim LS, Benseler SM, Tyrrell PN, et al., Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients. Ann Rheum Dis. 2012; 71 (10): 1686-91.
32. Markula-Patjas KP, Valta HL, Kerttula LI, et al., Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis. J Rheumatol. 2012; 39 (2): 365-73.
33. Boyce BF, Schwarz EM, Xing L,. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol. 2006; 18 (4): 427-32.
34. Kobayashi K, Takahashi N, Jimi E, et al., Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000; 191 (2): 275-86.
35. Clark EM, Ness AR, Tobias JH,. Vigorous physical activity increases fracture risk in children irrespective of bone mass: a prospective study of the independent risk factors for fractures in healthy children. J Bone Miner Res. 2008; 23 (7): 1012-22.
36. Kim JE, Hsieh MH, Soni BK, Zayzafoon M, Allison DB,. Childhood obesity as a risk factor for bone fracture: a mechanistic study. Obesity (Silver Spring). 2013; 21 (7): 1459-66.
37. Jones IE, Williams SM, Goulding A,. Associations of birth weight and length, childhood size, and smoking with bone fractures during growth: evidence from a birth cohort study. Am J Epidemiol. 2004; 159 (4): 343-50.
38. Flynn J, Foley S, Jones G,. Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty?: an eight-year prospective study. J Bone Miner Res. 2007; 22 (9): 1463-7.
39. Bishop N, Arundel P, Clark E, et al., Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2013 Pediatric Official Positions. J Clin Densitom. 2014; 17 (2): 275-80.
40. Halton J, Gaboury I, G, rant R, et al., Canadian STOPP Consortium. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res. 2009; 24 (7): 1326-34.